Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 1988; Volume 33,Issue 2
  • You have access
    Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus.
    E J Nestler and J F Tallman
    Molecular Pharmacology February 1988, 33 (2) 127-132;
  • You have access
    Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
    M Bouvier, M Hnatowich, S Collins, B K Kobilka, A Deblasi, R J Lefkowitz and M G Caron
    Molecular Pharmacology February 1988, 33 (2) 133-139;
  • You have access
    Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat.
    G D Bellward, T Chang, B Rodrigues, J H McNeill, S Maines, D E Ryan, W Levin and P E Thomas
    Molecular Pharmacology February 1988, 33 (2) 140-143;
  • You have access
    Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
    S Akiyama, M M Cornwell, M Kuwano, I Pastan and M M Gottesman
    Molecular Pharmacology February 1988, 33 (2) 144-147;
  • You have access
    Diethyl ether as a substrate for acetone/ethanol-inducible cytochrome P-450 and as an inducer for cytochrome(s) P-450.
    J F Brady, M J Lee, M Li, H Ishizaki and C S Yang
    Molecular Pharmacology February 1988, 33 (2) 148-154;
  • You have access
    Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
    A C Andorn, B R Bacon, A T Nguyen-Hunh, S J Parlato and J A Stitts
    Molecular Pharmacology February 1988, 33 (2) 155-162;
  • You have access
    Binding of [125I]-N-(p-aminophenethyl)spiroperidol to the D-2 dopamine receptor in the neurointermediate lobe of the rat pituitary gland: a thermodynamic study.
    T Agui, N Amlaiky, M G Caron and J W Kebabian
    Molecular Pharmacology February 1988, 33 (2) 163-169;
  • You have access
    Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
    J M Bidlack, W E O'Malley and R Schulz
    Molecular Pharmacology February 1988, 33 (2) 170-177;
  • You have access
    Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    A Dumuis, M Sebben and J Bockaert
    Molecular Pharmacology February 1988, 33 (2) 178-186;
  • You have access
    Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    F J Ehlert
    Molecular Pharmacology February 1988, 33 (2) 187-194;
  • You have access
    Phenothiazines and haloperidol block Ca-activated K channels in rat forebrain synaptosomes.
    C G Benishin, B K Krueger and M P Blaustein
    Molecular Pharmacology February 1988, 33 (2) 195-201;
  • You have access
    Multiple saxitoxin-binding sites in bullfrog muscle: tetrodotoxin-sensitive sodium channels and tetrodotoxin-insensitive sites of unknown function.
    E Moczydlowski, J Mahar and A Ravindran
    Molecular Pharmacology February 1988, 33 (2) 202-211;
  • You have access
    Calcium-dependent regulation of phosphorylase activation in a fast-twitch oxidative-glycolytic skeletal muscle.
    L P Garetto, R C Carlsen, J H Lee and D A Walsh
    Molecular Pharmacology February 1988, 33 (2) 212-217;
  • You have access
    Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
    F L Stassen, G Heckman, D Schmidt, M T Papadopoulos, P Nambi, H Sarau, N Aiyar, M Gellai and L Kinter
    Molecular Pharmacology February 1988, 33 (2) 218-224;
  • You have access
    Daunomycin-DNA dissociation kinetics.
    D R Phillips, P C Greif and R C Boston
    Molecular Pharmacology February 1988, 33 (2) 225-230;
  • You have access
    6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
    B Astroff, T Zacharewski, S Safe, M P Arlotto, A Parkinson, P Thomas and W Levin
    Molecular Pharmacology February 1988, 33 (2) 231-236;
  • You have access
    Photoaffinity labeling of human placental monoamine oxidase-A by 4-fluoro-3-nitrophenyl azide.
    M C Hsu and J C Shih
    Molecular Pharmacology February 1988, 33 (2) 237-241;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 33, Issue 2
1 Feb 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics